Antonio Tito Fojo

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Evaluation of survival after chemo-immunotherapy in veterans with extensive-stage small cell lung cancer and brain metastases.

  Journal of Clinical Oncology · 2026-05-28

• A phase 1, first-in-human study of DS9051, a novel targeted protein degradation molecule, in patients with advanced/metastatic adrenocortical carcinoma (ACC) or metastatic castration-resistant prostate cancer (mCRPC).

  Journal of Clinical Oncology · 2026-05-28

• Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colorectal Cancer

  Journal of Clinical Oncology · 2025-12-05

• 409 Real-world outcomes for patients with extensive-stage small cell lung cancer treated with chemo-immunotherapy in the veterans affair system

  Regular and Young Investigator Award Abstracts · 2025-11-01 · 1 citations

• Cancer interception during treatment: using growth kinetics to create a continuous variable for assessing disease response

  The Oncologist · 2025-10-18

• Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents

  Nature Reviews Endocrinology · 2025-08-13

• 760 | NOVEL CTCL RISK STRATIFIER INTEGRATING LYMPH NODE VOLUMETRICS AND mSWAT TO PREDICT SURVIVAL AND THERAPY RESPONSE

  Hematological Oncology · 2025-06-01

• Outcomes of initial vs delayed docetaxel therapy in veterans with metastatic hormone sensitive prostate cancer and high volume of disease.

  Journal of Clinical Oncology · 2025-05-28

• Supporting Patients with Cancer after Dobbs v. Jackson Women’s Health Organization

  UNC Libraries · 2025-04-22

• Abstract 6314: Development of g-rate based random forest machine learning model to predict overall survival for patients with metastatic prostate cancer

  Cancer Research · 2025-04-21

• Guidance for discussants of randomized cancer trials at major meetings

  European Journal of Cancer · 2025-03-07 · 3 citations

• Dose optimisation to improve access to effective cancer medicines

  The Lancet Oncology · 2025-03-01 · 11 citations

• <i>g</i> -Rate–based machine learning model to predict overall survival (OS) in patients with metastatic prostate cancer (mPC) while on treatment.

  Journal of Clinical Oncology · 2025-02-10

• Survival and Treatment Response in CTCL Can be Predicted Using Volumetric Lymph Node Size and Dynamic Changes in Lymph Node Size and Skin Score

  Blood · 2024-11-05

• Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents

  Nature Reviews Endocrinology · 2024-08-27 · 2 citations

• International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents

  Nature Reviews Endocrinology · 2024-08-15 · 40 citations

• 256 Skin scoring growth kinetics correlate with progression-free survival in cutaneous T-cell lymphoma

  Journal of Investigative Dermatology · 2024-07-19